All authors participated in producing the manuscript, With all the support of clinical crafting solutions provided by the funder. All authors read and accepted the submitted Edition on the manuscript. Inhibition of galectin-3 with GB1211 was not linked to any cure- or dose-related trends and there were no clinically considerable https://chen776yjt8.wizzardsblog.com/profile